FOX 29: With San Antonio facing record-breaking heat, some businesses are adjusting to stay safe
July 15, 2022
Dr. Shawn Varney, Emergency Medicine, is quoted in this story. Read More
University Police to train at Mays Cancer Center
July 15, 2022
There will be an increased police presence in and around Mays Cancer Center on July 30.
Planned power outage set for August 12
July 15, 2022
A power outage for the Dental Building, Basic Science Building, adjacent lecture halls and Garage B has been scheduled for August 12 from 8:00 p.m. to 2:00 a.m.
Texas Public Radio: Fronteras: Latino involvement in clinical trials involves overcoming cultural, physical and institutional barriers
July 15, 2022
Dr. Amelie Ramirez and Dr. Patricia Chalela, Population Health Sciences/Institute for Health Promotion Research, were interviewed in this podcast. Listen Now
Texas Public Radio: What should people know about the omicron subvariant?
July 15, 2022
Dr. Jason Bowling, Medicine-Infectious Diseases, was an invited guest on this podcast. Listen Now
Nathan Wiederhold receives Billy H. Cooper Award for contributions to diagnostic clinical mycology
July 15, 2022
Nathan Wiederhold, PharmD, professor of pathology and laboratory medicine and director of the Fungus Testing Laboratory at UT Health San Antonio, received the Medical Mycological Society of the Americas Billy H. Cooper Award for continued outstanding c …
Ivanhoe.com: Fast tracked leukemia drug saves lives
July 14, 2022
Dr. Ruben Mesa, executive director of the Mays Cancer Center, is shown in an interview he gave this spring that recently appeared on stations nationwide. Watch Video
Internal Medicine Residency Program gains health equity curriculum grant
July 14, 2022
PRIME program will pair residents with community health workers for educational experiences. With financial support from leading internal medicine organizations, UT Health San Antonio will launch “Promotores and Residents in Internal Medicine for Equit …
Oral pill improves care of patients with bone marrow cancer: Study
July 14, 2022
Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Can …
Chemical risk assessment not up to par, researchers say
July 14, 2022
How much is an “acceptable dose” of a pollutant? Are existing studies to measure safety adequate? A systematic literature review by UT Health San Antonio researchers suggests that the current system of chemical risk assessment is inadequate and contrad …